Symphogen Reports New Data on Anti-EGFR Monoclonal Antibody Mixture PipelineReview.com (press release) COPENHAGEN, Denmark I June 2, 2013 I Symphogen, a private biopharmaceutical company developing recombinant antibody mixtures, announced today at the 2013 Annual Meeting of the American Society of Clinical Oncology ( ASCO) the results of two ... |
